Literature DB >> 8396168

A system for characterizing cellular and molecular events in programmed neuronal cell death.

R N Pittman1, S Wang, A J DiBenedetto, J C Mills.   

Abstract

A model system has been established in which PC12 cells are converted to neuronal-like cells that undergo transcription-dependent cell death following removal of NGF. Nineteen sublines of PC12 cells were tested to establish parameters for making cells dependent on NGF for survival. In most sublines, a relatively small percentage of cells become dependent on NGF for survival, and following removal of NGF, most of the cells begin proliferating in serum-containing medium. In several sublines, however, a significant percentage of cells die following removal of NGF. One of these sublines, PC6-3, can be grown under conditions in which 90% of the cells undergo transcription-dependent cell death following removal of NGF in either serum-free or serum-containing medium. Fourteen hours after removing NGF, 50% of the cells are committed to die, while initial morphological signs of cell death as determined by time-lapse videomicroscopy occur 2-6 hr later and include loss of neurites followed by a 1-3 hr period of active membrane "blebbing" and protrusions. Cell death can be blocked by the RNA synthesis inhibitor actinomycin D, the protein synthesis inhibitor cycloheximide, KCl, basic fibroblast growth factor, or dibutryl-cAMP, but not by epidermal growth factor, leupeptin, or the endonuclease inhibitor aurintricarboxylic acid (ATA). Removal of NGF activates an endonuclease that causes nucleosomal laddering of the DNA; however, endonuclease activity does not appear to be required for cell death. In agreement with previous studies (Batistatou and Greene, 1991; Rukenstein et al., 1991) demonstrating that naive PC12 cells undergo transcription-independent cell death when shifted into serum-free medium in the absence of growth factors, all cell lines tested except for one die when cultured in RPMI medium lacking growth factors. DNA fragmentation is a prominent feature of transcription-independent cell death, and death can be blocked with NGF, ATA, and dibutryl-cAMP but not with actinomycin D or KCl. The PC12 model system described here should be useful for identifying cell death genes and for characterizing cellular and molecular events in programmed neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396168      PMCID: PMC6576452     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells.

Authors:  P K Davis; G V Johnson
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

3.  Allele-specific silencing of dominant disease genes.

Authors:  Victor M Miller; Haibin Xia; Ginger L Marrs; Cynthia M Gouvion; Gloria Lee; Beverly L Davidson; Henry L Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

Review 4.  Signaling of neuronal cell death by the p75NTR neurotrophin receptor.

Authors:  E J Coulson; K Reid; P F Bartlett
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

5.  Unfolding-resistant translocase targeting: a novel mechanism for outer mitochondrial membrane localization exemplified by the Bbeta2 regulatory subunit of protein phosphatase 2A.

Authors:  Ruben K Dagda; Chris A Barwacz; J Thomas Cribbs; Stefan Strack
Journal:  J Biol Chem       Date:  2005-05-27       Impact factor: 5.157

6.  The first cysteine-rich domain of the receptor GFRalpha1 stabilizes the binding of GDNF.

Authors:  Heidi Virtanen; Jianmin Yang; Maxim M Bespalov; Jukka O Hiltunen; Veli-Matti Leppänen; Nisse Kalkkinen; Adrian Goldman; Mart Saarma; Pia Runeberg-Roos
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

7.  Androgen receptor overexpression is neuroprotective in experimental stroke.

Authors:  Patricia Ayala; Masayoshi Uchida; Kozaburo Akiyoshi; Jian Cheng; Joel Hashimoto; Taiping Jia; Oline K Ronnekleiv; Stephanie J Murphy; Kristine M Wiren; Patricia D Hurn
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

8.  Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Authors:  Eric B Dammer; Martin Göttle; Duc M Duong; John Hanfelt; Nicholas T Seyfried; H A Jinnah
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

Review 9.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

10.  Growth control of C6 glioma in vivo by nerve growth factor.

Authors:  Shigeyoshi Kimura; Atsuo Yoshino; Yoichi Katayama; Takao Watanabe; Takao Fukushima
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.